Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Dec 6;11(12):1957.
doi: 10.3390/cancers11121957.

Ovarian Cancer Dissemination-A Cell Biologist's Perspective

Affiliations
Review

Ovarian Cancer Dissemination-A Cell Biologist's Perspective

Sadaf Farsinejad et al. Cancers (Basel). .

Abstract

Epithelial ovarian cancer (EOC) comprises multiple disease states representing a variety of distinct tumors that, irrespective of tissue of origin, genetic aberrations and pathological features, share common patterns of dissemination to the peritoneal cavity. EOC peritoneal dissemination is a stepwise process that includes the formation of malignant outgrowths that detach and establish widespread peritoneal metastases through adhesion to serosal membranes. The cell biology associated with outgrowth formation, detachment, and de novo adhesion is at the nexus of diverse genetic backgrounds that characterize the disease. Development of treatment for metastatic disease will require detailed characterization of cellular processes involved in each step of EOC peritoneal dissemination. This article offers a review of the literature that relates to the current stage of knowledge about distinct steps of EOC peritoneal dissemination, with emphasis on the cell biology aspects of the process.

Keywords: fallopian tube secretory epithelial cells; integrins; myosin; ovarian cancer; peritoneal dissemination.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
EOC outgrowth formation, dissociation, and colonization.
Figure 2
Figure 2
Stages of EOC metastasis.

References

    1. Hirst J., Crow J., Godwin A. Ovarian Cancer Genetics: Subtypes and Risk Factors. Ovarian Cancer. Pathog. Treat. 2018;1 doi: 10.5772/intechopen.72705. - DOI
    1. Zhai Y., Wu R., Schwartz D.R., Darrah D., Reed H., Kolligs F.T., Nieman M.T., Fearon E.R., Cho K.R. Role of beta-catenin/T-cell factor-regulated genes in ovarian endometrioid adenocarcinomas. Am. J. Pathol. 2002;160:1229–1238. doi: 10.1016/S0002-9440(10)62550-3. - DOI - PMC - PubMed
    1. McConechy M.K., Ding J., Senz J., Yang W., Melnyk N., Tone A.A., Prentice L.M., Wiegand K.C., McAlpine J.N., Shah S.P., et al. Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles. Mod. Pathol. 2014;27:128–134. doi: 10.1038/modpathol.2013.107. - DOI - PMC - PubMed
    1. Wiegand K.C., Shah S.P., Al-Agha O.M., Zhao Y., Tse K., Zeng T., Senz J., McConechy M.K., Anglesio M.S., Kalloger S.E., et al. ARID1A mutations in endometriosis-associated ovarian carcinomas. N. Engl. J. Med. 2010;363:1532–1543. doi: 10.1056/NEJMoa1008433. - DOI - PMC - PubMed
    1. Zhou J., Wu S.G., Wang J., Sun J.Y., He Z.Y., Jin X., Zhang W.W. The Effect of Histological Subtypes on Outcomes of Stage IV Epithelial Ovarian Cancer. Front. Oncol. 2018;8:577. doi: 10.3389/fonc.2018.00577. - DOI - PMC - PubMed

LinkOut - more resources